-
Mashup Score: 10For Those About to MOC, We Salute You - 5 day(s) ago
If an oncologist participates in a 1-hour multidisciplinary tumor board but does not report it to the American Board of Internal Medicine (ABIM), did it happen? This question vexes me and so many of my colleagues as we try (I believe) to stay on top of the many advances in our field and meet the needs of our patients while also complying with the credentialing requirements of the ABIM. That oncologists and many other clinicians are concerned with the amount of time and money required to maintain credential
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 29
Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today the U.S. Food and Drug Administration (FD
Source: www.businesswire.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 29
Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today the U.S. Food and Drug Administration (FD
Source: www.businesswire.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 29
Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today the U.S. Food and Drug Administration (FD
Source: www.businesswire.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 29
Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today the U.S. Food and Drug Administration (FD
Source: www.businesswire.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 29
Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today the U.S. Food and Drug Administration (FD
Source: www.businesswire.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 7University program puts Missouri school in world’s top 10 - 2 month(s) ago
MISSOURI (KSNF) — One university in the Show-Me State receives high marks on a global scale. Washington University in St. Louis (WUSTL) is ranked 8th in the world when it comes to their health scie…
Source: www.fourstateshomepage.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0In vivo ablation of NFκB cascade effectors alleviates disease burden in myeloproliferative neoplasms - John T. Milliken Department of Medicine - 2 month(s) ago
Study in Blood dissecting the role of NFκB signaling effectors in MPN disease biology Stephen T. Oh, MD, PhD, Co-Chief and Associate Professor of Medicine, Division of Hematology, Department of Medicine, Washington University School of Medicine in St. Louis, and has been published in Blood. The WashU group of researchers previously identified hyperactivation of NFκB […]
Source: internalmedicine.wustl.eduCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 12
Herbicide and pesticide exposure [e.g., agent orange (AO)] is associated with an increased risk of multiple myeloma (MM) due to the contaminant, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). However, it is unclear whether TCDD/AO exposure (AO exposure hereafter) …
Source: www.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4Blues announce 25th Anniversary Hockey Fights Cancer Night initiatives for Dec. 12 | St. Louis Blues - 5 month(s) ago
ST. LOUIS – The St. Louis Blues are preparing to recognize the 25th Anniversary of the National Hockey League’s fight against cancer when they host the Detroit Red Wings for Hockey Fights Cancer Night on Tuesday, Dec. 12. In conjunction with the celebration and the team’s continued efforts to raise
Source: www.nhl.comCategories: General Medicine News, Hem/OncsTweet
"For Those About to MOC, We Salute You"--great editorial in @JCO_ASCO And if you have comments/thoughts about @ABIMFoundation MOC in Oncology email your comments to MOC@asco.org @AaronGoodman33 @VincentRK https://t.co/ZDtG6ISzQv https://t.co/AUqLH7j5WX https://t.co/LMX53PNIjw